Eiger BioPharmaceuticals (EIGR) stock forecast for 2022 – 2027

Are you interested in Eiger BioPharmaceuticals, Inc. stocks prediction? If yes, then on this page you will find useful information about the dynamics of the EIGR stock price in 2022-2027. Is EIGR a good long term stock? When should I take profit in Eiger BioPharmaceuticals stock? Buy or sell stock? Will EIGR stock price go up? What are analysts’ forecasts for EIGR stock?
Forecst.com predicts future values using technical analysis of a large number of analytical parameters. EIGR stock returns are also predicted based on historical data.

According to our research, EIGR stock is a bad long-term investment. EIGR share price has been in a bear cycle for the past year. Eiger BioPharmaceuticals, Inc. stock trend is negative.

Eiger BioPharmaceuticals company info

Industry Biotechnology
Address 2155 Park Boulevard, Palo Alto, CA, 94306, United States
Website https://www.eigerbio.com

Forecasting

52 Week High: 26.2591 USD
52 Week Low: 0.00000101 USD
1 Year Forecast: 2.2736 USD
5 Year Forecast: 0 USD

Agilent Technologies info

Market Cap: 145.59M
52 Week Change: -6.0897%
52 Week High: 13.49 USD
52 Week Low: 3.53 USD
Beta: 1.26064
50 Day Moving Average: 4.87
90 Day Moving Average: 5.736
200 Day Moving Average: 6.73
Resistance Level: 4.687
Pivot Point: 4.27028
Support Level: 3.93924
Enterprise Value: 98,026,552
Forward P/E: -1.91
Forward EPS: -2.06
Profit Margin: 0.00%
Shares Outstanding: 33,975,800
EBITDA: -1.33
Held Percent Institutions: 68.97%
PEG Ratio (5Y): 0
Trailing EPS: -0.921

Eiger BioPharmaceuticals stock forecasts for 2022-2027

DateOpen PriceClose PriceChange

Eiger BioPharmaceuticals Stock Forecast for 2022

March 2022 11.76 12.87 9.44%
April 2022 12.87 0 -100%
May 2022 0 0 -100%
June 2022 0 0 -100%
July 2022 0 0 -100%
August 2022 0 0 -100%
September 2022 0 0 -100%
October 2022 0 0 -100%
November 2022 0 0 -100%
December 2022 0 12.24 -100%

Eiger BioPharmaceuticals Stock Forecast for 2023

January 2023 10.89 2.94 -73%
February 2023 2.04 8.82 332.35%
March 2023 10.89 13.13 20.57%
April 2023 10.89 0 -100%
May 2023 0 0 -100%
June 2023 0 0 -100%
July 2023 0 0 -100%
August 2023 0 0 -100%
September 2023 0 0 -100%
October 2023 0 0 -100%
November 2023 0 0 -100%
December 2023 0 10.78 -100%

Eiger BioPharmaceuticals Stock Forecast for 2024

January 2024 10 2.04 -79.6%
February 2024 0 8.91 -79.6%
March 2024 12.12 12.74 5.12%
April 2024 10.78 0 -100%
May 2024 0 0 -100%
June 2024 0 0 -100%
July 2024 0 0 -100%
August 2024 0 0 -100%
September 2024 0 0 -100%
October 2024 0 0 -100%
November 2024 0 0 -100%
December 2024 0 9.9 -100%

Eiger BioPharmaceuticals Stock Forecast for 2025

January 2025 8.82 0.99 -88.78%
February 2025 0.99 8 708.08%
March 2025 13.86 11.11 -19.84%
April 2025 10.1 0 -100%
May 2025 0 0 -100%
June 2025 0 0 -100%
July 2025 0 0 -100%
August 2025 0 0 -100%
September 2025 0 0 -100%
October 2025 0 0 -100%
November 2025 0 0 -100%
December 2025 0 9.09 -100%

Eiger BioPharmaceuticals Stock Forecast for 2026

January 2026 8.16 1.01 -87.62%
February 2026 1 4.95 395%
March 2026 10 9.8 -2%
April 2026 8.82 0 -100%
May 2026 0 0 -100%
June 2026 0 0 -100%
July 2026 0 0 -100%
August 2026 0 0 -100%
September 2026 0 0 -100%
October 2026 0 0 -100%
November 2026 0 0 -100%
December 2026 0 6.86 -100%

Eiger BioPharmaceuticals Stock Forecast for 2027

January 2027 7.84 1.02 -86.99%